Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ani, ARS, Bloomsbury Genetic Therapies, Byondis, Clearmind, Decibel, Hefei Tianhui, Immpact, Innovent, Lianbio, Novavax, Nuvectis, Oramend, Pyxis, Regeneron, Sisaf.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Celcuity, Innoviva, Kintor, Neurocentrx, Neurocrine, Pfizer, Qilu, Sanofi, Sofie.